Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92121


Purpose:

The purpose of this study is to assess the weight loss effect of lorcaserin during and at the end of 1 year of treatment in overweight and obese patients with Type II diabetes mellitus treated with metformin, sulfonylurea (SFU), or either agent in combination with other oral hypoglycemic agents.


Criteria:

Inclusion Criteria: - Overweight/obese men and women with type 2 diabetes mellitus that is managed with oral anti-hyperglycemic agent(s). - Body mass index (BMI) 27 to 45 kg/m2, inclusive. - Ability to complete a 1 year study Exclusion Criteria: - Pregnancy - Use of insulin in any form, exenatide (Byetta) or pramlintide (Symlin) within 3 months prior to screening - History of symptomatic heart valve disease - Serious or unstable current or past medical conditions


NCT ID:

NCT00603291


Primary Contact:

Study Director
William Shanahan, MD
Arena Pharmaceuticals


Backup Contact:

N/A


Location Contact:

San Diego, California 92121
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.